A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor’s metabolism.
November 29, 2010
October 09, 2010
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will be inducted today into the American Academy of Arts and Sciences, alongside some of the world’s other most distinguished scholars, artists and institutional leaders.
August 09, 2010
Stefan Habelitz, an engineer and materials scientist, is blazing a new research trail by investigating tooth enamel in the UCSF School of Dentistry's Marshall Lab, where researchers fruitfully focus on every facet of teeth, knowing they’re nothing to take for granted…
July 27, 2010
UCSF has hired two senior managers to strengthen the University’s research enterprise.
July 21, 2010
Larissa Podust, PhD, is working on a new drug for Chagas disease, a neglected scourge.
May 20, 2010
Former Intel Corp. chief executive Andy Grove has pledged $1.5 million to two University of California campuses – San Francisco and Berkeley – to jointly launch the first program of its kind aimed at accelerating the translation of cutting-edge research into advances in patient care.
February 24, 2010
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
February 11, 2010
Researchers, who are interested in taking their research from the bench to the bedside, are encouraged to apply for a catalyst award by March 1.
January 21, 2010
UCSF is proceeding with the construction of the neurosciences building at Mission Bay, where some of the world’s best scientists and clinicians will collaborate to prevent and cure diseases of the brain.
January 06, 2010
QB3 researchers at the UCSF Sandler Center for Basic Research in Parasitic Diseases are preparing to apply for FDA approval to test an Investigational New Drug (IND) for Chagas disease, in what could become the first drug to emerge from UCSF without an industry partner.